Price Chart

Profile

Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
URL https://www.roche.com
Investor Relations URL https://www.roche.com/investors.htm
HQ State/Province N/A
Sector Health Care
Industry Pharmaceuticals
Equity Style Large Cap/Blend
Next Earnings Release Jan. 31, 2025 (est.)
Last Earnings Release Jul. 25, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Mar. 14, 2024

Profile

Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
URL https://www.roche.com
Investor Relations URL https://www.roche.com/investors.htm
HQ State/Province N/A
Sector Health Care
Industry Pharmaceuticals
Equity Style Large Cap/Blend
Next Earnings Release Jan. 31, 2025 (est.)
Last Earnings Release Jul. 25, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Mar. 14, 2024